TP53 and prostate carcinoma: Although studies on ferroptosis in prostate cancer are still limited, the fundamental principles governing this process, particularly its regulation through pathways like the tumor protein p53 (p53) pathway and lipid peroxidation, suggest its potential as a promising therapeutic strategy for this malignancy (14–16).